#2 Guillermo Morales - CEO Innoventyx
BioTech IQ - Un podcast de Ammon Rivera
Catégories:
Dr. Morales discusses how COVID-19 affects the clinical trial supply chain, IP Strategy, and transitioning from pre-clinical to clinical.Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/
